| Encysive Pharmaceuticals, Inc. - SWOT Analysis |  | Author: Datamonitor
Buy New: $125.00
Format: Download: Pdf
Media: Digital
Pages: 14
| |
| Editorial Reviews:
Product Description
Datamonitor's Encysive Pharmaceuticals - SWOT Analysis company profile is the essential source for top-level company data and information. Encysive Pharmaceuticals - SWOT Analysis examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Encysive Pharmaceuticals (Encysive), a wholly owned subsidiary of Pfizer, is a biopharmaceutical company engaged in the discovery, development and commercialization of novel, synthetic, small molecule compounds to address unmet medical needs. The company’s R&D programs are primarily focused on the treatment and prevention of interrelated diseases of the vascular endothelium and utilize its expertise in the inflammatory cascade, and vascular diseases. The company is headquartered in Texas, Houston and employed 148 people as of December 2007. Pfizer completed the acquisition of Encysive for about $195 million in June 2008. The company recorded revenues of $35.9 million during the financial year (FY) ended December 2007, an increase of 89.1% over FY2006. Increase in revenues in FY2007 was primarily due to the significant growth in the sales of Thelin, the company’s drug for pulmonary arterial hypertension. The operating loss of the company was $100.7 million during FY2007, as compared with an operating loss of $109.4 million over FY2006. The net loss was $100.7 million in FY2007, as compared with a net loss of $109.3 million over FY2006.
Scope of the Report- Provides all the crucial information on Encysive Pharmaceuticals required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting Encysive Pharmaceuticals in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of Encysive Pharmaceuticals
- Data is supplemented with details on Encysive Pharmaceuticals history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from Encysive Pharmaceuticals
Reasons to Purchase- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available
|
|
|
Powered by Associate-O-Matic
| |
top